TherapeuticsMD (TXMD) EBT Margin (2011 - 2026)

TherapeuticsMD (TXMD) posted EBT Margin of 14.23% for Q1 2026, up 121.9% on a QoQ basis from 64.95% in Q4 2025, and up 18420.0% year-over-year from N/an in Q1 2025.

TherapeuticsMD (TXMD) EBT Margin (2011 - 2026) Analysis & Trends

TherapeuticsMD's EBT Margin history runs 16 years deep, the most recent figure standing at 14.23% for Q1 2026.

  • Quarterly EBT Margin rose 18420.0% year-over-year to 14.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.52% (up 12313.0% YoY) and the FY2025 annual result came in at 21.61%, up 11144.0% from the prior year.
  • EBT Margin was 14.23% for Q1 2026 at TherapeuticsMD, up from 64.95% in the prior quarter.
  • Across five years, EBT Margin topped out at 70.67% in Q4 2022 and bottomed at 4273.85% in Q2 2022.
  • A 5-year average of 942.04% and a median of 258.47% in 2024 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin tumbled 408842 bps — and 2023, when it surged 372145 bps.
  • TherapeuticsMD's EBT Margin stood at 70.67% in 2022, then plunged by 578 bps to 337.74% in 2023, then jumped by 104 bps to 12.44% in 2024, then tumbled by 622 bps to 64.95% in 2025, then jumped by 122 bps to 14.23% in 2026.
  • Business Quant data shows TXMD's EBT Margin at 14.23% in Q1 2026, 64.95% in Q4 2025, and 6.38% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 TherapeuticsMD 280,159.99 -8.14 Mn - 14.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.23%
Dec 31, 2025 -64.95%
Sep 30, 2025 6.38%
Jun 30, 2025 57.25%
Mar 31, 2025 -169.97%
Dec 31, 2024 12.44%
Sep 30, 2024 -103.66%
Jun 30, 2024 -448.72%
Mar 31, 2024 -258.47%
Dec 31, 2023 -337.74%
Sep 30, 2023 -2,705.66%
Jun 30, 2023 -552.40%
Mar 31, 2023 -555.29%
Dec 31, 2022 70.67%
Sep 30, 2022 -4,133.05%
Jun 30, 2022 -4,273.85%
Mar 31, 2022 -2,571.94%
Dec 31, 2021 268.50%
Sep 30, 2021 -186.65%
Jun 30, 2021 -185.44%